Sign the e-card for Alem Matthees!

The name of Australian patient Alem Matthees has become familiar in the last few days since a tribunal ruled that Queen Mary University of London (QMUL) must release to him the anonymised raw data from the PACE trial. Matthees requested in March 2014 under the Freedom of Information Act.
The decision is widely regarded as a landmark victory for patients in their efforts to get acknowledgement of serious problems with the analyses used in the trial.
Now the ME/CFS Society of WA has started an e-card to thank Matthees, and we encourage you to sign, to help show our community’s appreciation to him. No registration is necessary.
PACE’s results are influential in the UK and elsewhere in supporting the use of graded exercise therapy and a special form of activity-encouraging cognitive behavioural therapy for ME/CFS, widely seen as inappropriate by patients.
Matthees requested data from the study in order to perform the main outcome and recovery analyses that were specified in the study protocol but abandoned once the trial was underway. The new analyses included a threshold for recovery in which patients would be considered successfully treated even if their disability score worsened during the trial to almost the level of the average patient with Class II congestive heart failure.
So far, The Lancet, who published the study’s main outcomes, has ignored calls for reanalysis of the data from a group of over 40 scientists, and the study authors and QMUL have ignored a petition signed by over 12,000 patients with a similar request.
An appeal by QMUL against the tribunal decision remains a possibility, but would only be allowed on a point of law rather than on the basis of new facts or arguments. Meanwhile, journalist and public health expert Dr. David Tuller of the University of California, Berkeley, who has written extensively on PACE, described the tribunal outcome as the result of “amazing work” by Matthees.
[button_color url=”http://www.groupcard.com/c/8l2DPogN98e” content=”Sign the card here” target=”http://www.groupcard.com/c/8l2DPogN98e”]

Facebook
Twitter
WhatsApp
Email

2 thoughts on “Sign the e-card for Alem Matthees!”

  1. Dear alan,
    \
    well done. as a fellow CFS sufferer, when the exercise was suggested to me, I nearly fell over.
    luckily i did my own internet research to see that this research was not supported by the ME community. goodness knows how many people have ben harmed by this, which can now stop.
    thanks
    wendy

Comments are closed.

Latest News

navy blue square. there are two white lines at the top and bottom of the square. The #MEAction logo in at the top of the image. The words #MEAction Georgia Voice of the Patient in coordination with the Center for Disease Control and Prevention & Emory School of Nursing.

#MEAction Georgia: Voice of the Patient in Coordination with CDC & Emory School on Nursing

Back in September, #MEAction Georgia State Chapter partnered with the Centers for Disease Control and Prevention (CDC) and Emory School of Nursing to host, Voice of the Patient: A Panel Discussion with #MEAction Georgia. This event was a continuation of #MEAction Georgia’s #MillionsMissing 2024: #TeachMETreatME programming. Erin Lee and Liz Burlingame of the #MEAction Georgia

Read More »
a light blue square image with medical instruments/tools as a border (pill bottles, scales, needles, covid protein spike, etc). At the top of the image is the Home Test to Treat Program logo, in blue font: Findings Summary. Below that the #MEAction logo and Body Politic Logo.

Home Test To Treat – Findings Summary

#MEAction and Body Politic collaborated last spring, with a new national telehealth program, Home Test to Treat. We are now able to share initial findings from the program! Here are some highlights: 80K + enrolled in the program across the country! 40K + test distributed 6K + individuals treated for COVID-19 or flu 5.6K+ organizations

Read More »
Scroll to Top